1464 articles
DELL (Technology)

Dell Technologies secured a five-year, $9.7 billion Pentagon contract to provide Microsoft software and cloud services to the U.S. military. The deal follows Dell CEO Michael Dell's $6.25 billion pledge to fund 'Trump accounts' for children and comes amid the company's close relationship with President Trump. Pentagon officials say the contract will consolidate software licensing and save approximately $422 million annually.

Show details
AMWL (Healthcare) AMZN (Consumer Cyclical)

Amazon is appointing Dr. Roy Schoenberg, co-founder of telehealth company Amwell, to lead its healthcare unit starting July 1, 2025. He replaces Neil Lindsay, who has run the division since November 2021 and will leave Amazon by year-end after 16 years with the company. The move puts a physician with healthcare industry experience in charge of one of Amazon's fastest-growing business segments.

Show details
HPQ (Technology)

HP exceeded Wall Street's second-quarter revenue and profit estimates, driven by strong demand for AI-optimized PCs and the Windows 11 upgrade cycle following Microsoft's end of Windows 10 support in October. The company navigated memory chip shortages affecting the PC industry, with enterprises shifting toward higher-margin premium devices during the transition.

Show details
SNPS (Technology)

Synopsys, a $100 billion chip design software maker, has settled with activist investor Elliott Investment Management by granting a board seat to Elliott's managing partner Jesse Cohn. Elliott had built a multi-billion dollar stake and pushed for margin improvements over roughly two months, initially seeking three board seats. Synopsys' stock has risen approximately 20% since Elliott's involvement became public.

Show details
MRVL (Technology)

Marvell Technology forecast second-quarter revenue of $2.70 billion, exceeding analyst estimates of $2.60 billion, driven by strong demand for its custom AI processors and networking chips used in data center infrastructure. The company is benefiting from surging capital spending by cloud providers on AI infrastructure, which is expected to exceed prior levels as tech giants ramp up investments.

Show details
CRM (Technology)

Salesforce reported quarterly earnings and revenue above Wall Street expectations, with Agentforce AI tools surpassing $1 billion in annualized revenue for the first time. However, the company issued lighter-than-expected full-year revenue guidance due to weakness in its marketing, commerce, and Tableau segments, as well as integration challenges from its $9.6 billion Informatica acquisition.

Show details
AMZN (Consumer Cyclical) SNOW (Technology)

Snowflake announced a $6 billion infrastructure deal with Amazon Web Services on May 27, 2026. The investment is specifically tied to AWS's Graviton processors and AI chip infrastructure, representing a major commitment to cloud-based AI capabilities.

Show details
ABBV (Healthcare)

The U.S. Food and Drug Administration approved AbbVie's drug on Wednesday for the treatment of blastic plasmacytoid dendritic cell neoplasm, a very rare type of blood cancer. The approval provides a new treatment option for patients with this uncommon malignancy.

Show details
P-SPAC (Unknown) SPCX (Unknown)

The Federal Aviation Administration ordered SpaceX to investigate a mishap involving its Super Heavy booster, which crashed into the Gulf of Mexico during the Starship Flight 12 test on May 22, 2026. The FAA will oversee the investigation and must approve SpaceX's findings and corrective actions before the Starship-Super Heavy vehicle can return to flight. No injuries or public property damage were reported.

Show details
EWC (Unknown) EWW (Unknown)

The Trump administration announced three rounds of trade negotiations with Mexico to revamp USMCA, starting this week and continuing through July, while notably excluding Canada from talks. The U.S. plans to maintain tariffs on goods from both Mexico and Canada, departing from the decades-old tariff-free North American trade zone. The move highlights deepening U.S.-Canada tensions, with Canada being criticized for retaliating against U.S. tariffs alongside China.

Show details
BAC (Financial Services)

Bank of America CEO Brian Moynihan forecasts a 15% year-over-year increase in trading revenue for Q2, attributing the strong comparison to last year's 'liberation quarter' when markets experienced volatility from higher U.S. tariffs. The bank also expects positive performance in investment banking and wealth management segments.

Show details
P-OPEA (Unknown)

The OpenAI Foundation announced a $250 million commitment to help workers and economies navigate AI-driven disruption through grants, partnerships, and direct programs. The initiative will fund research on AI's labor market impact, support displaced workers and communities, and explore broader distribution of AI's economic benefits. This marks the foundation's first such commitment as concerns grow about AI-related job losses.

Show details
BA (Industrials)

Boeing is increasing 737 production to 47 jets per month from 42 after consulting with the Federal Aviation Administration. CEO Kelly Ortberg announced the production ramp-up at an investor conference, stating the target rate should be achieved within the next couple of months. The move signals Boeing's efforts to scale up manufacturing following regulatory oversight.

Show details
CVX (Energy)

Chevron shareholders voted down a proposal to separate the roles of board chair and CEO at the company's annual meeting on May 27. The proposal was brought by the National Legal and Policy Center, but Chevron opposed it, arguing for flexibility in board structure. The rejection follows a similar outcome at ConocoPhillips earlier in May.

Show details
AMZN (Consumer Cyclical)

Amazon Web Services is now selling its AI shopping technology, built on Alexa for Shopping, to other retailers as a commercial service. The tool allows retailers to launch customized AI shopping assistants for their own stores in as little as 60 days. This move follows Amazon's established pattern of commercializing internally-developed technology, similar to its approach with AWS cloud services.

Show details
RNLSY (Consumer Cyclical)

Gucci will become the title sponsor of Renault's Alpine Formula One team starting in 2027, with the team racing as 'Gucci Racing Alpine Formula One Team' in the brand's colors. This marks the first time a luxury brand has lent its name to an F1 racing team, as Gucci seeks to boost visibility and revive sales after years of decline. The partnership reflects the luxury industry's growing embrace of exclusive sporting events as demand for traditional luxury goods weakens.

Show details
PYPL (Financial Services) TCEHY (Communication Services)

Tencent Financial Technology announced that U.S. PayPal users can now make purchases across China using WeChat Pay's QR-code merchant network through a connection between TenPay Global and PayPal World. The service will be expanded to PayPal users in other markets gradually, with Tencent offering incentives including temporary fee waivers through 2026 to encourage adoption.

Show details
AMZN (Consumer Cyclical)

Amazon invested over £15 billion ($20 billion) in the United Kingdom during 2025, maintaining its trajectory toward a planned multi-year investment commitment through 2027. The investments included new operational sites, expanded studio facilities, office space, and a drone delivery trial, while the company reported over £30 billion in UK revenues and employed approximately 75,000 people.

Show details
MRK (Healthcare)

Merck announced that China's agriculture ministry has approved its vaccine for infectious bronchitis in chickens, targeting strain 4-91. The approval is significant as China is the world's largest chicken-rearing country with over 5 billion birds, making it a major market for the U.S. pharmaceutical company.

Show details
AZN (Healthcare)

The U.S. FDA has extended its review deadline for AstraZeneca's experimental breast cancer pill camizestrant to assess additional data. The delay postpones the regulatory decision on the drug, which is under review for treating breast cancer. AstraZeneca announced the extension on Wednesday, though no new timeline was specified.

Show details